http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1524893-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c41cad1060112c68fb09672bc9b7635e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 1988-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1989-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b6d8aeebc7a9afe442869e23abd8873
publicationDate 1989-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SU-1524893-A1
titleOfInvention Method of treatment of glaucoma
abstract This invention relates to ophthalmology. The aim of the invention is to reduce postoperative complications. After retro-bulbar anesthesia and akinesia, the conjunctiva is opened in a semicircular 6 mm from the limbus and concentric to it. After hemostasis with a trephine, 2 mm in diameter, the required number of scleral perforations (11 to 22) is calculated in a staggered manner on the basis of an increase in the initial coefficient of ease of outflow after a single trepanation at 0.01 mm 3 / min / mm Hg. Then, using tweezers and razor blades, the intended scleral flaps are excised. A solution of sulfacyl sodium is instilled into the wound. On conjunctiva impose bioshov. Under the conjunctiva, antibiotic and steroid hormone solutions are administered. Aseptic dressing is applied.
priorityDate 1988-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4022878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451856544

Total number of triples: 14.